BRAINLIFE Brain Tumor Medical Database

Integrative MedicinePSK and other Polysaccharides  


Hokkaido Igaku Zasshi 1984 Sep;59(5):639-42 (Animal Study)


Abstract

[Effect of PS-K on experimental neurogenic tumors in rats induced by ethylnitrosourea]

[Article in Japanese]

Tokuda K, Abe H, Aida T, Kaneko S, Tsuru M

The effect of PS-K as immunomodulator was studied in Fischer rats bearing neurogenic tumors induced transplacentally by ENU.
114 rats were divided into control and PS-K treated groups.
All rats were subjected to an autopsy at death and all of central nervous system were examined macroscopically.
Final neurogenic tumor incidence in PS-K treated groups was significantly lower than that in the control group, but distribution of these neurogenic tumors and number of neurogenic tumors in a rat remained unchanged between the control and the each PS-K treated groups.
Survival time of PS-K treated groups did not increase than the control group.
From these experiments, it might be that induction of neurogenic tumors may be suppressed by administration of PS-K.

PMID: 6510885 [PubMed - indexed for MEDLINE]

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6510885&dopt=Abstract


 

This website is certified by Health On the Net Foundation. Click to verify. HOMECURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTSBRAIN TUMOR MEDICAL DATABASE SERVICES TREATMENT OPTIONS FOR GLIOBLASTOMA
DATABASE by Section: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
DATABASE by Tumor: Glioblastoma | Medulloblastoma | Other TumorsSERVICES: About BrainLife | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications | Search | SiteMap
This site complies with the HONcode standard for trustworthy health information: verify here bottom